| Linagliptin Helps Renally Impaired Diabetics - Renal and Urology News |
|
|
Renal and Urology News SAN DIEGO—Linagliptin, a dipeptidyl peptidase (DPP)-4 inhibitor, appears to be a good treatment option for patients with type 2 diabetes and severe renal impairment, researchers announced at the 71st Scientific Sessions of the American Diabetes |